Bausch Health (TSX:BHC) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


TSX:BHC Bausch Health Companies Inc TSX:BHC
64 GF Score
Price C$7.10
GF Value C$11.06
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Bausch Health's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TSX:BHC vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Bausch Health's Margin of Safety % (DCF Earnings Based) falls into.


TSX:BHC
64GF Score
Bausch Health Companies Inc TSX:BHC
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (TSX:BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of C$7.10 is trading 35.8% below its estimated GF Value™ of C$11.06. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for TSX:BHC:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: C$11.06 vs. price of C$7.10 (35.8% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the TSX:BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
64GF Score

Get the complete analysis for TSX:BHC

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$7.10
Price
C$11.06
GF Value